0 Canadian Stock Exchange News - February 1, 2024Revive Therapeutics Explores the Use of Bucillamine for Long COVIDTORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a […]Read More
0 Canadian Stock Exchange News - January 31, 2024Revive Therapeutics Ltd. Announces Closing of the First Tranche of Its Private Placement for Gross Proceeds of $913,500NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER […]Read More
0 Canadian Stock Exchange News - January 31, 2024Vortex Energy Announces Further Extension of Marketing CampaignVANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) […]Read More
0 Canadian Stock Exchange News - January 31, 2024PharmAla releases Profitable Q1 Interim Financial Statement and Business UpdateVANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), […]Read More
0 Canadian Stock Exchange News - January 31, 2024FORZA LITHIUM AND PLANET GREEN METALS ANNOUNCE MERGER ON A 1:1 SHARE EXCHANGE BASISVANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Forza Lithium Corp. (CSE: FZ) (“Forza” or the “Company”) is pleased […]Read More
0 Canadian Stock Exchange News - January 31, 2024Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)NAPANEE, Ontario, Jan. 31, 2024 (GLOBE NEWSWIRE) — Lophos Holdings Inc. (“Lophos”, or the “Company”) (CSE:MESC) is thrilled to provide […]Read More
0 Canadian Stock Exchange News - January 31, 2024AYR Announces Closing Date for Previously Announced Plan of Arrangement is targeted for on or around February 7, 2024MIAMI, Jan. 31, 2024 (GLOBE NEWSWIRE) — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically […]Read More
0 Canadian Stock Exchange News - January 31, 2024Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKDVANCOUVER, British Columbia, Jan. 31, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: […]Read More
0 Canadian Stock Exchange News - January 31, 2024Global Helium Corp. Announces Operational Update and Shares Independent Resource Estimate From First Manyberries WellCALGARY, Alberta, Jan. 31, 2024 (GLOBE NEWSWIRE) — Global Helium Corp. (“HECO” or the “Company”) (CSE: HECO, OTC: HECOF) is […]Read More
0 Canadian Stock Exchange News - January 31, 2024ATHA Energy Discovers High-Priority Electromagnetic Target Coincident With 11.3% U308 Boulder SampleNORTH BEACON AND NORTH CREST PROJECT HIGHLIGHTS Uriniferous boulder train discovered on the North Beacon Project – with grades of […]Read More